English
简体中文
Total: £ 56.28
Published Date: 2025-09-02 | Pages: 109 | Tables: 107 | Medical Care
The global market for AI Chronic Disease Management was valued at US$ 1550 million in the year 2024 and is projected to reach a revised size of US$ 5056 million by 2031, growing at a CAGR of 18.4% during the forecast period.
AI chronic disease management uses artificial intelligence (AI) to digitally and intelligently manage the entire lifecycle of chronic diseases (such as diabetes, hypertension, coronary heart disease, and chronic obstructive pulmonary disease). Its core approach involves real-time collection and analysis of patients' electronic medical records, test data, wearable device monitoring information, and lifestyle data through big data, machine learning, natural language processing, knowledge graphs, and intelligent algorithms. This enables disease risk prediction, personalized intervention, medication guidance, rehabilitation tracking, and remote follow-up. Compared to traditional manual management, AI chronic disease management can significantly improve diagnosis and treatment efficiency, reduce physician burden, lower medical costs, and help patients develop long-term healthy behaviors. It has broad application value in smart hospitals, internet medical platforms, medical insurance cost control, and family health management, and is a key direction for the future development of digital healthcare and precision medicine.
North American market for AI Chronic Disease Management is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI Chronic Disease Management is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI Chronic Disease Management in Home is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI Chronic Disease Management include Teladoc Health, S3 Connected Health, Cognizant, Omada Health, WellDoc, Epic Systems, Pathmate, EveryDose, Aptar Digital Health, VITech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI Chronic Disease Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Chronic Disease Management.
The AI Chronic Disease Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Chronic Disease Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Chronic Disease Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teladoc Health
S3 Connected Health
Cognizant
Omada Health
WellDoc
Epic Systems
Pathmate
EveryDose
Aptar Digital Health
VITech
Virta Health
Glooko
Dexcom
Philips
Siemens
Assure Tech
Alibaba Group
Ping An Insurance
Fangzhou Inc
Jianhai Technology
Lepu Medical
Sinocare
Xunfei Healthcare
Segment by Type
Mobile Applications
Wearable Hardware
Cloud Platform
Others
Segment by Application
Home
Commercial
Medical
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI Chronic Disease Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Chronic Disease Management Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Mobile Applications
1.2.3 Wearable Hardware
1.2.4 Cloud Platform
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI Chronic Disease Management Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Home
1.3.3 Commercial
1.3.4 Medical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Chronic Disease Management Market Perspective (2020-2031)
2.2 Global AI Chronic Disease Management Growth Trends by Region
2.2.1 Global AI Chronic Disease Management Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Chronic Disease Management Historic Market Size by Region (2020-2025)
2.2.3 AI Chronic Disease Management Forecasted Market Size by Region (2026-2031)
2.3 AI Chronic Disease Management Market Dynamics
2.3.1 AI Chronic Disease Management Industry Trends
2.3.2 AI Chronic Disease Management Market Drivers
2.3.3 AI Chronic Disease Management Market Challenges
2.3.4 AI Chronic Disease Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Chronic Disease Management Players by Revenue
3.1.1 Global Top AI Chronic Disease Management Players by Revenue (2020-2025)
3.1.2 Global AI Chronic Disease Management Revenue Market Share by Players (2020-2025)
3.2 Global Top AI Chronic Disease Management Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Chronic Disease Management Revenue
3.4 Global AI Chronic Disease Management Market Concentration Ratio
3.4.1 Global AI Chronic Disease Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Chronic Disease Management Revenue in 2024
3.5 Global Key Players of AI Chronic Disease Management Head office and Area Served
3.6 Global Key Players of AI Chronic Disease Management, Product and Application
3.7 Global Key Players of AI Chronic Disease Management, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Chronic Disease Management Breakdown Data by Type
4.1 Global AI Chronic Disease Management Historic Market Size by Type (2020-2025)
4.2 Global AI Chronic Disease Management Forecasted Market Size by Type (2026-2031)
5 AI Chronic Disease Management Breakdown Data by Application
5.1 Global AI Chronic Disease Management Historic Market Size by Application (2020-2025)
5.2 Global AI Chronic Disease Management Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Chronic Disease Management Market Size (2020-2031)
6.2 North America AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Chronic Disease Management Market Size by Country (2020-2025)
6.4 North America AI Chronic Disease Management Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Chronic Disease Management Market Size (2020-2031)
7.2 Europe AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Chronic Disease Management Market Size by Country (2020-2025)
7.4 Europe AI Chronic Disease Management Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI Chronic Disease Management Market Size (2020-2031)
8.2 Asia-Pacific AI Chronic Disease Management Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Chronic Disease Management Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Chronic Disease Management Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI Chronic Disease Management Market Size (2020-2031)
9.2 Latin America AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Chronic Disease Management Market Size by Country (2020-2025)
9.4 Latin America AI Chronic Disease Management Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Chronic Disease Management Market Size (2020-2031)
10.2 Middle East & Africa AI Chronic Disease Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Chronic Disease Management Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Chronic Disease Management Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teladoc Health
11.1.1 Teladoc Health Company Details
11.1.2 Teladoc Health Business Overview
11.1.3 Teladoc Health AI Chronic Disease Management Introduction
11.1.4 Teladoc Health Revenue in AI Chronic Disease Management Business (2020-2025)
11.1.5 Teladoc Health Recent Development
11.2 S3 Connected Health
11.2.1 S3 Connected Health Company Details
11.2.2 S3 Connected Health Business Overview
11.2.3 S3 Connected Health AI Chronic Disease Management Introduction
11.2.4 S3 Connected Health Revenue in AI Chronic Disease Management Business (2020-2025)
11.2.5 S3 Connected Health Recent Development
11.3 Cognizant
11.3.1 Cognizant Company Details
11.3.2 Cognizant Business Overview
11.3.3 Cognizant AI Chronic Disease Management Introduction
11.3.4 Cognizant Revenue in AI Chronic Disease Management Business (2020-2025)
11.3.5 Cognizant Recent Development
11.4 Omada Health
11.4.1 Omada Health Company Details
11.4.2 Omada Health Business Overview
11.4.3 Omada Health AI Chronic Disease Management Introduction
11.4.4 Omada Health Revenue in AI Chronic Disease Management Business (2020-2025)
11.4.5 Omada Health Recent Development
11.5 WellDoc
11.5.1 WellDoc Company Details
11.5.2 WellDoc Business Overview
11.5.3 WellDoc AI Chronic Disease Management Introduction
11.5.4 WellDoc Revenue in AI Chronic Disease Management Business (2020-2025)
11.5.5 WellDoc Recent Development
11.6 Epic Systems
11.6.1 Epic Systems Company Details
11.6.2 Epic Systems Business Overview
11.6.3 Epic Systems AI Chronic Disease Management Introduction
11.6.4 Epic Systems Revenue in AI Chronic Disease Management Business (2020-2025)
11.6.5 Epic Systems Recent Development
11.7 Pathmate
11.7.1 Pathmate Company Details
11.7.2 Pathmate Business Overview
11.7.3 Pathmate AI Chronic Disease Management Introduction
11.7.4 Pathmate Revenue in AI Chronic Disease Management Business (2020-2025)
11.7.5 Pathmate Recent Development
11.8 EveryDose
11.8.1 EveryDose Company Details
11.8.2 EveryDose Business Overview
11.8.3 EveryDose AI Chronic Disease Management Introduction
11.8.4 EveryDose Revenue in AI Chronic Disease Management Business (2020-2025)
11.8.5 EveryDose Recent Development
11.9 Aptar Digital Health
11.9.1 Aptar Digital Health Company Details
11.9.2 Aptar Digital Health Business Overview
11.9.3 Aptar Digital Health AI Chronic Disease Management Introduction
11.9.4 Aptar Digital Health Revenue in AI Chronic Disease Management Business (2020-2025)
11.9.5 Aptar Digital Health Recent Development
11.10 VITech
11.10.1 VITech Company Details
11.10.2 VITech Business Overview
11.10.3 VITech AI Chronic Disease Management Introduction
11.10.4 VITech Revenue in AI Chronic Disease Management Business (2020-2025)
11.10.5 VITech Recent Development
11.11 Virta Health
11.11.1 Virta Health Company Details
11.11.2 Virta Health Business Overview
11.11.3 Virta Health AI Chronic Disease Management Introduction
11.11.4 Virta Health Revenue in AI Chronic Disease Management Business (2020-2025)
11.11.5 Virta Health Recent Development
11.12 Glooko
11.12.1 Glooko Company Details
11.12.2 Glooko Business Overview
11.12.3 Glooko AI Chronic Disease Management Introduction
11.12.4 Glooko Revenue in AI Chronic Disease Management Business (2020-2025)
11.12.5 Glooko Recent Development
11.13 Dexcom
11.13.1 Dexcom Company Details
11.13.2 Dexcom Business Overview
11.13.3 Dexcom AI Chronic Disease Management Introduction
11.13.4 Dexcom Revenue in AI Chronic Disease Management Business (2020-2025)
11.13.5 Dexcom Recent Development
11.14 Philips
11.14.1 Philips Company Details
11.14.2 Philips Business Overview
11.14.3 Philips AI Chronic Disease Management Introduction
11.14.4 Philips Revenue in AI Chronic Disease Management Business (2020-2025)
11.14.5 Philips Recent Development
11.15 Siemens
11.15.1 Siemens Company Details
11.15.2 Siemens Business Overview
11.15.3 Siemens AI Chronic Disease Management Introduction
11.15.4 Siemens Revenue in AI Chronic Disease Management Business (2020-2025)
11.15.5 Siemens Recent Development
11.16 Assure Tech
11.16.1 Assure Tech Company Details
11.16.2 Assure Tech Business Overview
11.16.3 Assure Tech AI Chronic Disease Management Introduction
11.16.4 Assure Tech Revenue in AI Chronic Disease Management Business (2020-2025)
11.16.5 Assure Tech Recent Development
11.17 Alibaba Group
11.17.1 Alibaba Group Company Details
11.17.2 Alibaba Group Business Overview
11.17.3 Alibaba Group AI Chronic Disease Management Introduction
11.17.4 Alibaba Group Revenue in AI Chronic Disease Management Business (2020-2025)
11.17.5 Alibaba Group Recent Development
11.18 Ping An Insurance
11.18.1 Ping An Insurance Company Details
11.18.2 Ping An Insurance Business Overview
11.18.3 Ping An Insurance AI Chronic Disease Management Introduction
11.18.4 Ping An Insurance Revenue in AI Chronic Disease Management Business (2020-2025)
11.18.5 Ping An Insurance Recent Development
11.19 Fangzhou Inc
11.19.1 Fangzhou Inc Company Details
11.19.2 Fangzhou Inc Business Overview
11.19.3 Fangzhou Inc AI Chronic Disease Management Introduction
11.19.4 Fangzhou Inc Revenue in AI Chronic Disease Management Business (2020-2025)
11.19.5 Fangzhou Inc Recent Development
11.20 Jianhai Technology
11.20.1 Jianhai Technology Company Details
11.20.2 Jianhai Technology Business Overview
11.20.3 Jianhai Technology AI Chronic Disease Management Introduction
11.20.4 Jianhai Technology Revenue in AI Chronic Disease Management Business (2020-2025)
11.20.5 Jianhai Technology Recent Development
11.21 Lepu Medical
11.21.1 Lepu Medical Company Details
11.21.2 Lepu Medical Business Overview
11.21.3 Lepu Medical AI Chronic Disease Management Introduction
11.21.4 Lepu Medical Revenue in AI Chronic Disease Management Business (2020-2025)
11.21.5 Lepu Medical Recent Development
11.22 Sinocare
11.22.1 Sinocare Company Details
11.22.2 Sinocare Business Overview
11.22.3 Sinocare AI Chronic Disease Management Introduction
11.22.4 Sinocare Revenue in AI Chronic Disease Management Business (2020-2025)
11.22.5 Sinocare Recent Development
11.23 Xunfei Healthcare
11.23.1 Xunfei Healthcare Company Details
11.23.2 Xunfei Healthcare Business Overview
11.23.3 Xunfei Healthcare AI Chronic Disease Management Introduction
11.23.4 Xunfei Healthcare Revenue in AI Chronic Disease Management Business (2020-2025)
11.23.5 Xunfei Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI Chronic Disease Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Mobile Applications
Table 3. Key Players of Wearable Hardware
Table 4. Key Players of Cloud Platform
Table 5. Key Players of Others
Table 6. Global AI Chronic Disease Management Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI Chronic Disease Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI Chronic Disease Management Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI Chronic Disease Management Market Share by Region (2020-2025)
Table 10. Global AI Chronic Disease Management Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI Chronic Disease Management Market Share by Region (2026-2031)
Table 12. AI Chronic Disease Management Market Trends
Table 13. AI Chronic Disease Management Market Drivers
Table 14. AI Chronic Disease Management Market Challenges
Table 15. AI Chronic Disease Management Market Restraints
Table 16. Global AI Chronic Disease Management Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI Chronic Disease Management Market Share by Players (2020-2025)
Table 18. Global Top AI Chronic Disease Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Chronic Disease Management as of 2024)
Table 19. Ranking of Global Top AI Chronic Disease Management Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI Chronic Disease Management Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI Chronic Disease Management, Headquarters and Area Served
Table 22. Global Key Players of AI Chronic Disease Management, Product and Application
Table 23. Global Key Players of AI Chronic Disease Management, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI Chronic Disease Management Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI Chronic Disease Management Revenue Market Share by Type (2020-2025)
Table 27. Global AI Chronic Disease Management Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI Chronic Disease Management Revenue Market Share by Type (2026-2031)
Table 29. Global AI Chronic Disease Management Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI Chronic Disease Management Revenue Market Share by Application (2020-2025)
Table 31. Global AI Chronic Disease Management Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI Chronic Disease Management Revenue Market Share by Application (2026-2031)
Table 33. North America AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI Chronic Disease Management Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI Chronic Disease Management Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI Chronic Disease Management Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI Chronic Disease Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI Chronic Disease Management Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI Chronic Disease Management Market Size by Country (2026-2031) & (US$ Million)
Table 48. Teladoc Health Company Details
Table 49. Teladoc Health Business Overview
Table 50. Teladoc Health AI Chronic Disease Management Product
Table 51. Teladoc Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 52. Teladoc Health Recent Development
Table 53. S3 Connected Health Company Details
Table 54. S3 Connected Health Business Overview
Table 55. S3 Connected Health AI Chronic Disease Management Product
Table 56. S3 Connected Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 57. S3 Connected Health Recent Development
Table 58. Cognizant Company Details
Table 59. Cognizant Business Overview
Table 60. Cognizant AI Chronic Disease Management Product
Table 61. Cognizant Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 62. Cognizant Recent Development
Table 63. Omada Health Company Details
Table 64. Omada Health Business Overview
Table 65. Omada Health AI Chronic Disease Management Product
Table 66. Omada Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 67. Omada Health Recent Development
Table 68. WellDoc Company Details
Table 69. WellDoc Business Overview
Table 70. WellDoc AI Chronic Disease Management Product
Table 71. WellDoc Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 72. WellDoc Recent Development
Table 73. Epic Systems Company Details
Table 74. Epic Systems Business Overview
Table 75. Epic Systems AI Chronic Disease Management Product
Table 76. Epic Systems Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 77. Epic Systems Recent Development
Table 78. Pathmate Company Details
Table 79. Pathmate Business Overview
Table 80. Pathmate AI Chronic Disease Management Product
Table 81. Pathmate Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 82. Pathmate Recent Development
Table 83. EveryDose Company Details
Table 84. EveryDose Business Overview
Table 85. EveryDose AI Chronic Disease Management Product
Table 86. EveryDose Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 87. EveryDose Recent Development
Table 88. Aptar Digital Health Company Details
Table 89. Aptar Digital Health Business Overview
Table 90. Aptar Digital Health AI Chronic Disease Management Product
Table 91. Aptar Digital Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 92. Aptar Digital Health Recent Development
Table 93. VITech Company Details
Table 94. VITech Business Overview
Table 95. VITech AI Chronic Disease Management Product
Table 96. VITech Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 97. VITech Recent Development
Table 98. Virta Health Company Details
Table 99. Virta Health Business Overview
Table 100. Virta Health AI Chronic Disease Management Product
Table 101. Virta Health Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 102. Virta Health Recent Development
Table 103. Glooko Company Details
Table 104. Glooko Business Overview
Table 105. Glooko AI Chronic Disease Management Product
Table 106. Glooko Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 107. Glooko Recent Development
Table 108. Dexcom Company Details
Table 109. Dexcom Business Overview
Table 110. Dexcom AI Chronic Disease Management Product
Table 111. Dexcom Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 112. Dexcom Recent Development
Table 113. Philips Company Details
Table 114. Philips Business Overview
Table 115. Philips AI Chronic Disease Management Product
Table 116. Philips Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 117. Philips Recent Development
Table 118. Siemens Company Details
Table 119. Siemens Business Overview
Table 120. Siemens AI Chronic Disease Management Product
Table 121. Siemens Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 122. Siemens Recent Development
Table 123. Assure Tech Company Details
Table 124. Assure Tech Business Overview
Table 125. Assure Tech AI Chronic Disease Management Product
Table 126. Assure Tech Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 127. Assure Tech Recent Development
Table 128. Alibaba Group Company Details
Table 129. Alibaba Group Business Overview
Table 130. Alibaba Group AI Chronic Disease Management Product
Table 131. Alibaba Group Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 132. Alibaba Group Recent Development
Table 133. Ping An Insurance Company Details
Table 134. Ping An Insurance Business Overview
Table 135. Ping An Insurance AI Chronic Disease Management Product
Table 136. Ping An Insurance Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 137. Ping An Insurance Recent Development
Table 138. Fangzhou Inc Company Details
Table 139. Fangzhou Inc Business Overview
Table 140. Fangzhou Inc AI Chronic Disease Management Product
Table 141. Fangzhou Inc Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 142. Fangzhou Inc Recent Development
Table 143. Jianhai Technology Company Details
Table 144. Jianhai Technology Business Overview
Table 145. Jianhai Technology AI Chronic Disease Management Product
Table 146. Jianhai Technology Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 147. Jianhai Technology Recent Development
Table 148. Lepu Medical Company Details
Table 149. Lepu Medical Business Overview
Table 150. Lepu Medical AI Chronic Disease Management Product
Table 151. Lepu Medical Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 152. Lepu Medical Recent Development
Table 153. Sinocare Company Details
Table 154. Sinocare Business Overview
Table 155. Sinocare AI Chronic Disease Management Product
Table 156. Sinocare Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 157. Sinocare Recent Development
Table 158. Xunfei Healthcare Company Details
Table 159. Xunfei Healthcare Business Overview
Table 160. Xunfei Healthcare AI Chronic Disease Management Product
Table 161. Xunfei Healthcare Revenue in AI Chronic Disease Management Business (2020-2025) & (US$ Million)
Table 162. Xunfei Healthcare Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. AI Chronic Disease Management Picture
Figure 2. Global AI Chronic Disease Management Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI Chronic Disease Management Market Share by Type: 2024 VS 2031
Figure 4. Mobile Applications Features
Figure 5. Wearable Hardware Features
Figure 6. Cloud Platform Features
Figure 7. Others Features
Figure 8. Global AI Chronic Disease Management Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI Chronic Disease Management Market Share by Application: 2024 VS 2031
Figure 10. Home Case Studies
Figure 11. Commercial Case Studies
Figure 12. Medical Case Studies
Figure 13. Others Case Studies
Figure 14. AI Chronic Disease Management Report Years Considered
Figure 15. Global AI Chronic Disease Management Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global AI Chronic Disease Management Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global AI Chronic Disease Management Market Share by Region: 2024 VS 2031
Figure 18. Global AI Chronic Disease Management Market Share by Players in 2024
Figure 19. Global AI Chronic Disease Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by AI Chronic Disease Management Revenue in 2024
Figure 21. North America AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America AI Chronic Disease Management Market Share by Country (2020-2031)
Figure 23. United States AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe AI Chronic Disease Management Market Share by Country (2020-2031)
Figure 27. Germany AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific AI Chronic Disease Management Market Share by Region (2020-2031)
Figure 35. China AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America AI Chronic Disease Management Market Share by Country (2020-2031)
Figure 43. Mexico AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa AI Chronic Disease Management Market Share by Country (2020-2031)
Figure 47. Israel AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE AI Chronic Disease Management Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Teladoc Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 51. S3 Connected Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 52. Cognizant Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 53. Omada Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 54. WellDoc Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 55. Epic Systems Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 56. Pathmate Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 57. EveryDose Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 58. Aptar Digital Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 59. VITech Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 60. Virta Health Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 61. Glooko Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 62. Dexcom Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 63. Philips Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 64. Siemens Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 65. Assure Tech Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 66. Alibaba Group Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 67. Ping An Insurance Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 68. Fangzhou Inc Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 69. Jianhai Technology Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 70. Lepu Medical Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 71. Sinocare Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 72. Xunfei Healthcare Revenue Growth Rate in AI Chronic Disease Management Business (2020-2025)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
